DYN   $34.73  -1.89% Market Closed After Close 35.06 0.95%

Dyne Therapeutics Inc
Total Cash 778.84M
totalCashPerShare 7.757
EBITDA -269.47M
Total Debt 25.72M
quickRatio 26.177
currentRatio 26.63
Total Revenue
debtToEquity 3.317
Revenue/Share
ROA -0.31454
ROE -0.52459997
grossProfits
freeCashflow -130.44M
operatingCashflow -219.01M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.62B
forwardPE -10.971875
floatShares 73.71M
sharesOutstanding 100.40M
sharesShort 8.88M
sharesShortPriorMonth 6.87M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.13%
Short Ratio help_outline 4.43%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 7.743
Price To Book help_outline 4.53
earningsQuarterlyGrowth
netIncomeToCommon -257.60M
trailingEps -3.58%
forwardEps -3.20%
enterpriseToEbitda -9.72
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.72 3Q 2024
institutionsCount 280
lastUpdated Oct. 16, 2024, 9:55 p.m.